Itolizumab (rDNA origin) – A Monoclonal Antibody | UPSC

Sansar LochanCurrent AffairsLeave a Comment

Itolizumab (rDNA origin), a monoclonal antibody which was already approved for severe chronic plaque psoriasis, has now been granted Restricted Emergency Use authorisation for COVID 19 patients by the Drugs Controller General of India (DCGI) based on clinical trials data. What is Itolizumab? Itolizumab (rDNA origin) is a monoclonal antibody that is already an approved drug of Biocon for severe chronic plaque psoriasis.  Itolizumab’s unique … Read More

Know about CogX 2020 and MyGov | UPSC

Sansar LochanCurrent Affairs, Science and TechLeave a Comment

India’s Artificial Intelligence (AI) enabled MyGov Corona Helpdesk has bagged two awards at the Global Leadership Summit and Festival of AI and Emerging Technology, CogX 2020. From the UPSC point of view, we are giving you some important information.  What is MyGov? MyGov is the world’s largest citizen engagement platform, which facilitates two-ways communication between the Government and Citizen and … Read More

Why does America want to back out of Open Skies Treaty?

Sansar LochanCurrent AffairsLeave a Comment

The United States has given notice that it will back out of the Open Skies Treaty (OST). This agreement allows countries to monitor signatories’ arms development by conducting surveillance flights over each other’s territories. History of Open Skies Treaty This treaty was signed in 1992 and came into force in 2002, allowing 34 countries — including the United States and … Read More